Stay updated on Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the previous v3.5.4, indicating a small page-build update with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-06-08T17:33:03.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a software version update.
    Difference
    0.0%
    Check dated 2026-05-18T05:48:14.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed platform/version revision was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:41:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:10:41.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The site update adds Revision: v3.5.0 and removes Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:14:32.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T12:51:59.000Z thumbnail image

Stay in the know with updates to Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.